Search
for
Sort by
Research 61–90 of 1000+
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Study of effect of myoinositol on menstrual irregularities and skin problems in polycystic ovarian syndrome cases
- A Systematic Review of the Potential Role of Cinnamomum spp. in Modulating Insulin Sensitivity and Hyperandrogenism in Polycystic Ovary Syndrome (PCOS)
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Surprisingly low infertility rate in married type 2 diabetic women: A rather curious paradox to the current opinion of insulin resistance as the joint pathogenesis of poly cystic ovary syndrome and type 2 diabetes mellitus
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Syndromes of Severe Insulin Resistance (SSIRs)
- Myo-inositol in polycystic ovary syndrome: a systematic review and positioning of its use
- Role of Metformin in Acanthosis Nigricans
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- Exploring Nanotechnology With Traditional Herbal Pharmacology: Nano Carrier-Based Phytochemical Delivery In PCOS Treatment
- Hirsutism due to polycystic ovarian syndrome: An integrative review of pathophysiology and management
- Management of women with hirsutism in Kosovo
- MON-369 Treatment of Nonclassic 11-Hydroxylase Deficiency with "Hair, Skin, and Nails," an Over-the-Counter, Insulin Sensitizing Vitamin/Mineral Supplement
- Botanical Treatment for Polycystic Ovary Syndrome
- Inositol versus Metformin administration in polycystic ovary syndrome patients
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Polycystic Ovary Syndrome
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Dermatology of androgen-related disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Obesity and the Polycystic Ovary Syndrome
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- The Hirsute Woman: Challenges in Evaluation and Management